Showing results (2141-2150 of 2,286) with videos related to

Sort By:
Pageof 229
Neurosurgical Focus|December 16, 2006
Phase II study of carboplatin (CBDCA) in progressive low-grade gliomasA Moghrabi, H S Friedman, D M Ashley, et al.
Journal of Medicinal Chemistry|September 1, 2020
Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine ProductionXiaohui Du, Jared Moore, Brian R Blank, et al.
Neuro-Oncology|December 15, 2010
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastomaJohn H Sampson, Kenneth D Aldape, Gary E Archer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 14, 2020
Resident mesenchymal vascular progenitors modulate adaptive angiogenesis and pulmonary remodeling via regulation of canonical Wnt signalingMegan E Summers, Bradley W Richmond, Swapna Menon, et al.
The Lancet. Child & Adolescent Health|April 2, 2023
Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trialEric M Thompson, Daniel Landi, Michael C Brown, et al.
Depression and Anxiety|June 30, 2020
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trialsOle Köhler-Forsberg, Louisa G Sylvia, Vicki Fung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Phase II trial of temozolomide in patients with progressive low-grade gliomaJennifer A Quinn, David A Reardon, Allan H Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2013
Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor modelsJie Lin, Deepak Sampath, Michelle A Nannini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II studyGamal Akabani, David A Reardon, R Edward Coleman, et al.
Cell Host & Microbe|October 16, 2015
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's DiseaseJames D Lewis, Eric Z Chen, Robert N Baldassano, et al.
Pageof 229